Evidence map›Paper›PMID 29762745›Full record

ArticleNeuro-oncology2018

Genome-wide association analysis identifies a meningioma risk locus at 11p15.5.

Elizabeth B Claus, Alex J Cornish, Peter Broderick, Joellen M Schildkraut, Sara E Dobbins, Amy Holroyd, Lisa Calvocoressi, Lingeng Lu, Helen M Hansen, Ivan Smirnov and 13 more

Open access · bronzeAbstract read
In one paragraph

Article in Neuro-oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Epidemiology of Brain and Other CNS Tumors.Current neurology and neuroscience reports · 2021
    Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. PleiotropicNeuro-oncology advances
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 8 institutions in 5 countries.

Elizabeth B ClausSchool of Public Health, Yale University, New Haven, Connecticut, USA.
Alex J CornishDivision of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
Peter BroderickDivision of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
Joellen M SchildkrautDepartment of Public Health Sciences, University of Virginia, Charlottesville, Virginia, USA.
Sara E DobbinsDivision of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
Amy HolroydSchool of Public Health, Yale University, New Haven, Connecticut, USA.
Lisa CalvocoressiSchool of Public Health, Yale University, New Haven, Connecticut, USA.
Lingeng LuSchool of Public Health, Yale University, New Haven, Connecticut, USA.
Helen M HansenSchool of Public Health, Yale University, New Haven, Connecticut, USA.
Ivan SmirnovSchool of Public Health, Yale University, New Haven, Connecticut, USA.
Kyle M WalshSchool of Public Health, Yale University, New Haven, Connecticut, USA.
Johannes SchrammSchool of Public Health, Yale University, New Haven, Connecticut, USA.
Per HoffmannSchool of Public Health, Yale University, New Haven, Connecticut, USA.
Markus M NöthenSchool of Public Health, Yale University, New Haven, Connecticut, USA.
Karl-Heinz JöckelSchool of Public Health, Yale University, New Haven, Connecticut, USA.
Anthony SwerdlowDivision of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
Signe Benzon LarsenUnit of Survivorship, The Danish Cancer Society Research Center, Copenhagen, Denmark.
Christoffer JohansenUnit of Survivorship, The Danish Cancer Society Research Center, Copenhagen, Denmark.
Matthias SimonUniversity of Bonn Medical School, Bonn, Germany.
Melissa BondySection of Epidemiology and Population Sciences, Department of Medicine and Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas, USA.
Margaret WrenschDivision of Neuroepidemiology, Department of Neurological Surgery, University of California San Francisco, San Francisco, California, USA.
Richard S HoulstonDivision of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
Joseph L WiemelsDivision of Neuroepidemiology, Department of Neurological Surgery, University of California San Francisco, San Francisco, California, USA.
Institute of Cancer Research · GBUniversity of California, San Francisco · USUniversity of Bonn · DEYale University · USDanish Cancer Society · DKBaylor College of Medicine · USBrigham and Women's Hospital · USUniversity of Virginia · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Tissue CoreP50CA097257 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Joseph F Costello · 2002 to 2026
$57.4M
GENETIC EPIDEMIOLOGY OF MALIGNANT GLIOMAR01CA052689 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WIENCKE, JOHN K., WRENSCH, MARGARET R. · 1991 to 2015
$20.5M
The Meningioma Consortium: Genome-Wide Association StudyR01CA151933 · NCI · YALE UNIVERSITY · PI CLAUS, ELIZABETH B. · 2010 to 2013
$3.7M
Meningioma: Risk Factors and Quality of LifeR01CA109468 · NCI · YALE UNIVERSITY · PI CLAUS, ELIZABETH B. · 2006 to 2010
$3.3M
Meningioma: Risk Factors and Quality of LifeR01CA109745 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WIEMELS, JOSEPH LEO · 2006 to 2010
$1.9M
Meningioma: Risk Factors and Quality of LifeR01CA109475 · NCI · DUKE UNIVERSITY · PI ILYASOVA, DORA · 2006 to 2010
$1.4M
Meningioma: Risk Factors and Quality of LifeR01CA109461 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI CLAUS, ELIZABETH B. · 2006 to 2010
$1.1M
NCI NIH HHS P50 CA097257NCI NIH HHS R01 CA052689NCI NIH HHS R01 CA109461NCI NIH HHS R01 CA109468NCI NIH HHS R01 CA109475NCI NIH HHS R01 CA109745NCI NIH HHS R01 CA151933
6 · The paper itself

Abstract

Background: Meningiomas are adult brain tumors originating in the meningeal coverings of the brain and spinal cord, with significant heritable basis. Genome-wide association studies (GWAS) have previously identified only a single risk locus for meningioma, at 10p12.31. Methods: To identify a susceptibility locus for meningioma, we conducted a meta-analysis of 2 GWAS, imputed using a merged reference panel from the 1000 Genomes Project and UK10K data, with validation in 2 independent sample series totaling 2138 cases and 12081 controls. Results: We identified a new susceptibility locus for meningioma at 11p15.5 (rs2686876, odds ratio = 1.44, P = 9.86 × 10-9). A number of genes localize to the region of linkage disequilibrium encompassing rs2686876, including RIC8A, which plays a central role in the development of neural crest-derived structures, such as the meninges. Conclusions: This finding advances our understanding of the genetic basis of meningioma development and provides additional support for a polygenic model of meningioma.

Indexed as

Genetic LociGenome-Wide Association StudyPolymorphism, Single NucleotideAdultAgedBiomarkers, TumorCase-Control StudiesChromosomes, Human, Pair 11FemaleFollow-Up StudiesGenetic Predisposition to DiseaseGenotypeHumansLinkage DisequilibriumMaleMeningeal NeoplasmsBiomarkers, Tumor

Identifiers

PMID29762745
PMCPMC6176799
OpenAlexW2802529689

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.